We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF
SBIO

60 hedge funds and large institutions have $71.7M invested in ALPS Medical Breakthroughs ETF in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

537% more call options, than puts

Call options by funds: $1.39M | Put options by funds: $218K

2.71% more ownership

Funds ownership: 32.69% → 35.39% (+2.7%)

8% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 13

4% less capital invested

Capital invested by funds: $74.8M → $71.7M (-$3.15M)

9% less funds holding

Funds holding: 66 → 60 (-6)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

Holders
60
Holders Change
-6
Holders Change %
-9.09%
% of All Funds
1.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
14
Reduced
13
Closed
10
Calls
$1.39M
Puts
$218K
Net Calls
+$1.17M
Net Calls Change
+$118K

Top Buyers

Rank Fund Capital Flow
1
PF
Phoenix Financial
Israel
+$2.84M
2
UBS Group
UBS Group
Switzerland
+$1.57M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$1.14M
4
Wells Fargo
Wells Fargo
California
+$1.13M
5
BPA
Beacon Pointe Advisors
California
+$1.09M

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$1.54M
2
Ameriprise
Ameriprise
Minnesota
-$1.29M
3
Citadel Advisors
Citadel Advisors
Florida
-$1.16M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$871K
5
RJA
Raymond James & Associates
Florida
-$462K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$412K -$871K -18,973 -68%
MC
27
Matisse Capital
Oregon
$343K – – –
SWP
28
Stratos Wealth Partners
Ohio
$279K – – –
CCC
29
Crescent Capital Consulting
Louisiana
$274K – – –
UCFA
30
United Capital Financial Advisors
Texas
$232K – – –
VNA
31
Valley National Advisers
Pennsylvania
$194K -$1.47K -32 -0.7%
William Blair & Company
32
William Blair & Company
Illinois
$174K +$176K +3,824 New
AWM
33
AllSquare Wealth Management
New York
$144K – – –
Northwestern Mutual Wealth Management
34
Northwestern Mutual Wealth Management
Wisconsin
$98K +$6.24K +136 +7%
KPCM
35
Kings Point Capital Management
New York
$73K – – –
CG
36
Cutler Group
California
$54K +$55.1K +1,200 New
US Bancorp
37
US Bancorp
Minnesota
$45K – – –
CFA
38
Cahill Financial Advisors
Minnesota
$23K +$22.9K +500 New
First Manhattan
39
First Manhattan
New York
$18K – – –
MCM
40
MV Capital Management
Maryland
$18K – – –
S
41
SignatureFD
Georgia
$18K – – –
LWANC
42
Laurel Wealth Advisors (North Carolina)
North Carolina
$17K – – –
APA
43
American Portfolios Advisors
New York
$15.6K – – –
OC
44
Oakworth Capital
Alabama
$14K – – –
TWM
45
Tradition Wealth Management
Minnesota
$14K – – –
TFS
46
TrustCore Financial Services
Tennessee
$10K – – –
Fidelity Investments
47
Fidelity Investments
Massachusetts
$10K +$4.18K +91 +72%
NFG
48
Next Financial Group
Texas
$10K +$4.59K +100 +95%
CFA
49
Carroll Financial Associates
North Carolina
$9K – – –
ADL
50
Asset Dedication LLC
California
$8K – – –
1
2
3

SBIO Hedge Fund Activity: Q3 2021 in Review

60 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q3 2021, worth a combined $71.7M — down 4.2% from $74.8M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of SBIO and 7 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 14 added.

The largest buyer was Phoenix Financial, adding an estimated $2.84M. The largest seller was Tower Research Capital (TRC), cutting an estimated $1.54M.

  • 60 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q3 2021, down from 66 in Q2 2021.
  • Funds reported $71.7M of ALPS Medical Breakthroughs ETF stock for Q3 2021, down 4.2% quarter-over-quarter.
  • 7 funds opened new ALPS Medical Breakthroughs ETF positions in Q3 2021 and 10 closed out, a net change of -3 holders.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q3 2021 was Phoenix Financial, an estimated $2.84M added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q3 2021 was Tower Research Capital (TRC), an estimated $1.54M sold.

Based on aggregated 13F filings for Q3 2021.